AlphaCrest Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,107
| Closed | -$298K | – | 1067 |
|
|
2022
Q3 | $298K | Buy |
12,107
+1,435
| +13% | +$35.3K | 0.02% | 1141 |
|
|
2022
Q2 | $259K | Sell |
10,672
-9,781
| -48% | -$237K | 0.01% | 1155 |
|
|
2022
Q1 | $527K | Sell |
20,453
-35,338
| -63% | -$911K | 0.03% | 870 |
|
|
2021
Q4 | $1.73M | Buy |
+55,791
| New | +$1.73M | 0.06% | 502 |
|
|
2021
Q3 | – | Sell |
-49,400
| Closed | -$721K | – | 1386 |
|
|
2021
Q2 | $721K | Buy |
+49,400
| New | +$721K | 0.03% | 806 |
|
|
2020
Q4 | – | Sell |
-12,500
| Closed | -$231K | – | 1276 |
|
|
2020
Q3 | $231K | Buy |
+12,500
| New | +$231K | 0.03% | 988 |
|
|
2020
Q1 | – | Sell |
-14,100
| Closed | -$200K | – | 1280 |
|
|
2019
Q4 | $200K | Sell |
14,100
-11,200
| -44% | -$159K | 0.02% | 1209 |
|
|
2019
Q3 | $293K | Buy |
+25,300
| New | +$293K | 0.02% | 1101 |
|